Bullet Train: US FDA User Fee Bill Is On Fast Track In House

 
• By Michael McCaughan

The House Energy & Commerce Committee is moving rapidly to complete work on a bipartisan reauthorization of the US FDA’s user fee programs – and it isn’t waiting for any riders that aren’t ready on time. For now, at least, that means the CURES 2.0 bill will have to find another track.

Frank Pallone says the user fee train is leaving the station
Energy & Commerce Committee Chair Frank Pallone (D-N.J.) has a schedule to keep. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock, Getty images

More from User Fees

More from Pathways & Standards